Targeting avian leukosis virus subgroup A vectors by using a TVA-VEGF bridge protein

Journal of Virology

Volumn 75, Issue 3, 2001, Pages 1571-1575

  Snitkovsky, S ^a   Niederman, T M J ^a   Mulligan, R C ^a   Young, J A T ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; PROLINE; TVA VEGF110 PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 2; VIRUS PROTEIN; VIRUS RECEPTOR; VIRUS VECTOR;

ARTICLE; AVIAN LEUKOSIS ONCOVIRUS; CONTROLLED STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN TARGETING; VIRUS ENVELOPE;

AVIAN LEUKOSIS VIRUS; AVIAN PROTEINS; ENDOTHELIAL GROWTH FACTORS; GENETIC VECTORS; LYMPHOKINES; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RECEPTORS, VIRUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035152288     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.3.1571-1575.2001     Document Type: Article

References (28)

1. A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor
2. Importance of cysteines in the LDLR-related domain of the subgroup A avian leukosis and sarcoma virus receptor for viral entry
3. Retroviral vectors preloaded with viral receptor-ligand bridge protein are targeted to specific cell types
4. Genetic analysis of the Rous sarcoma virus subgroup D env gene: Mammal tropism correlates with temperature sensitivity gp85
5. Vascular endothelial growth factor as a marker of tumor endothelium
6. CAR1, a TNFR-related protein, is a cellular receptor for cytopathic avian leukosis-sarcoma viruses and mediates apoptosis
7. VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells
8. Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor-positive cells
9. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: Concentration in tumor blood vessels
10. Tumor angiogenesis
11. Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate
12. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF
13. Vascular targeting of solid and ascites tumours with antibodies to vascular endothelial growth factor
14. Vascular permeability factor, an endothelial cell mitogen related to PDGF
15. The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency
16. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
17. The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells
18. Vascular endothelial growth factor is a secreted angiogenic mitogen
19. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant
20. Targeting the tumor vasculature: Inhibition of tumor growth by a vascular endothelial growth factor-toxin conjugate
21. Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-1-positive endothelial cell proliferation in vitro and angiogenesis in vivo
22. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
23. Cell-specific viral targeting mediated by a soluble retroviral receptor-ligand fusion protein
24. A TVA-single-chain antibody fusion protein mediates specific targeting of a subgroup A avian leukosis virus vector to cells expressing a tumor-specific form of the epidermal growth factor receptor
25. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor
26. Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma
27. Regulation of angiogenesis via vascular endothelial growth factor receptors
28. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor